BEFORE the introduction of the sulphonamide group of drugs, the treatment of infections due to the gonococcus was largely confined to the use of urinary antiseptics, irrigations of the urethra, and treatment of complications as they arose. More recently, vaccines and gonococcal antitoxin were added to these time-honoured methods in the hope that possibly a more rapid and successful cure might be attained. Crean (1937) remarks, however, that none of these methods has made any notable change in the length of time it takes to cure an uncomplicated acute case. With the introduction of chemotherapy, however, a new era in the treatment of gonorrheea was ushered in.
Despite the fact that the sulphonamides have now been in use for some three or four years, there is still considerable doubt on many aspects of the chemotherapeutic treatment of gonococcal infections, this doubt, in some cases, extending even to the question as to which is the most suitable preparation to use in the treatment of these conditions. There is still considerable doubt, too, as to the proper time for commencing chemotherapy: a number of authorities have advocated "delayed therapy," whereby chemotherapeutic treatment in acute gonorrhoea is withheld for some eight to twenty-one days in order to allow the body immunity mechanism to develop; during this waiting period, routine methods of treatment (i.e., urethral irrigations and vaccines) are carried out; other workers, on the other hand, commence chemotherapy as soon as the diagnosis of the disease has been established. Various schemes of dosage have been suggested, whilst difference of opinion still exists as to the total amount of the drug required and as to the total duration of treatment, whilst the vexed question of the advisability or otherwise of combining chemotherapy with routine methods of treatment has not been definitely settled.
Before a satisfactory statement can be made with regard to these points, a number of considerations demand attention, of which not the least important is the choice of the drug itself. There is now little doubt that the most efficient sulphonamide for use in gonococcal infections is M.&B. 693, and the present article is the outcome of an investigation made with that drug in the treatment of gonorrhoea in patients attending the Venereal Diseases Clinic at the Royal Victoria Hospital, Belfast. The cases investigated were mostly males, though the results obtained in a small series of female patients are also recorded. In a few cases, Uleron was the chemotherapeutic agent employed, either per se or before or after the use of M.&B. 693. Whilst the clinical research was being carried out, a study was also made of the absorption and excretion of M.&B. 693, and some of the toxic effects of both M.&B. 693 and Uleron were investigated at the same time. The dosage of the drugs ultimately employed and the duration of treatment decided upon were the result of this combined study, the object being to use what was considered to be a 79 minimal effective dosage of the drugs given over a minimal effective period of time, taking into consideration the toxic reactions produced by the drugs as well as their absorption and excretion. Some of the results obtained in the more pharmacological aspects of the investigations are described elsewhere in this issue of the Journal. PROCEDURE. The response to treatment in 230 cases of infections due to the gonococcus was studied. These cases consisted of 216 male and 14 female patients: they were divided up as follows:
(A) MALE: I. Treated (a) UNCOMPLICATED CASES-133 PATIENTS.
In twenty-eight of these patients, symptoms had been present for more than six weeks, in nine others the duration of the disease was doubtful, the remainder were "acute" cases, i.e., patients in whom symptoms had been present for less than six weeks. The actual duration of symptoms before chemotherapy and the number of patients treated were as follows T.O.C. were performed at varying intervals after the end of chemotherapy. They consisted of provocative doses of gonococcal vaccine (twenty millions), urethroscopic examination of the anterior urethra, and the passage of a large sound into the bladder, the urethra being massaged against the sound. Eighty-three patients had adjuvant treatment in addition to M.&B. 693, the remaining fifty having the drug only. The adjuvant treatment consisted of daily urethral irrigations, usually with 1/10,000 potassium permanganate, and in some cases weekly injections of gonococcal vaccine were also given. An alkaline powder was prescribed frequently where nausea following the use of the drug occurred.
A gross analysis of the results reveals the fact that a satisfactory response to chemotherapy was obtained in 128 cases (or over ninety-six per cent.), there were five (or 3.7 per cent.) failures, in eight cases (six per cent.) relapses were seen, and three cases exhibited complications during chemotherapy: the complications were all mild.
The 128 good results were classified as Group 1-Cured cases  ---69  Group 2-Probably cured cases  --20  Group 3-"Clinical cures" ---39 Of the sixty-nine cases in Group 1, fifty-five attended for a period varying from three to fifteen months from the end of chemotherapy: as in the other two groups, many of the patients in Group 1 are still reporting at intervals.
The cure-rate was so high in both acute and chronic cases that it seemed evident that neither "delayed therapy" nor adjuvant treatment made the slightest difference to the ultimate outcome. In order to confirm this, the failures, relapsed cases, and cases in whom complications developed during chemotherapy were analysed more fully.
ANALYSIS OF FAILURES.
Five patients failed to respond to chemotherapy with M.&B. 693. Of these, chemotherapy was commenced within two to nine days from the onset of symptoms in two cases, in two others the symptoms were present for six weeks and five and 81 a half months respectively. The duration of symptoms before chemotherapy in the fifth case was doubtful, as he had had M.&B. 693 at another centre before reporting at our clinic: he stated that his discharge had cleared up but had subsequently recurred. All five cases had adjuvant treatment in addition to chemotherapy. It was evident, therefore, that in these cases at least, neither "delayed therapy" nor adjuvant treatment had made any difference to the ultimate outcome. The cause of the failure was not always evident. In all cases chemotherapy was more prolonged than usual, whilst in several a larger dose of the drug than usual was employed, when it was seen that the condition was not responding satisfactorily to routine dosage. In one of these cases slight cyanosis developed with the increased dosage; the drug was withheld and the patient put on to routine methods of treatment. Actually, this patient's discharge had cleared up by the second morning on M.&B. 693, but small threads and pus cells continued to be present in the urine: he is still on treatment. When increased dosage failed to cure the condition in a second case, tab. sulphonamide-P (one gramme four times daily) was tried with a similar unsuccessful result, but the patient complained of such severe nausea and upset with the sulphanilamide that the drug had to be withheld on the third day. He too was started on routine measures of treatment, and is still attending the clinic. Whilst chemotherapy in a third case was again responsible for improvement in symptoms, the urine did not become clear, and continued to show considerable numbers of pus cells. The remaining two cases were treated subsequently with Uleron, and it was interesting to note that, as in the second case where a change of sulphonamide failed to produce a satisfactory result, so here a similar unsatisfactory response to the different sulphonamide was observed. Actually the discharge in both cases cleared up (after three "stosses" of Uleron in one case and after two "stosses" in the other), but both cases subsequently defaulted before an adequate follow-up and when considerable numbers of pus cells were still present in the urine. In one patient only could a definite cause be found to explain the chemotherapeutic failure: it was found here that the prostate was slightly enlarged and tender; daily gentle prostatic massage was instituted just before and during Uleron therapy, and his condition showed considerable improvement. The cause of failure in this case was probably due to the prostatitis, a condition to which Cokkinis and McElligott (1938) attributed a number of their failures with sulphanilamide. What the cause of this condition is, is doubtful, but these workers consider that it is a gonococcal prostatitis modified by chemotherapy into an atypical pathology: they have named the condition "sulphonamide prostate."
Apart from the fact that neither "delayed therapy" nor adjuvant treatment had influenced the results in these cases, a number of other points of interest arose. In the first place it became evident that where a rapid response to chemotherapy was not observed, even with increased dosage, continuation of the drug was useless, whilst it was also interesting to note that where M.&B. 693 had failed to bring about a successful issue, other sulphonamides were often no more successful. It has been suggested (Cokkinis and McElligott, 1938 ) that doses of the sulphonamides which are inadequate to produce a cure may cause abnormal resistance of the 82 organism to the drug: it is possible that the failures under discussion here may have responded if a higher dosage of M.&B. 693 had been given from the onset, and that the dosage employed had produced a "sulphonamide fast" organism.
Even if this could be proved, in the present state of our knowledge it is impossible to forecast which patient is going to show this atypical response, but their number would appear to be so small that it seems to be quite unjustifiable to expose the majority of patients to the dangers of toxicity which large doses of these drugs have been found to cause, for the benefit of this small minority. ANALYSIS OF RELAPSES.
Relapses occurred in eight of the uncomplicated cases of this series, a figure considerably below that found by other workers (Cokkinis and McElligott, 1939; Assinder and Knight, 1939; Gardner, 1939) . Four of these relapsed twice and four (one of whom had relapsed after previous Uleron chemotherapy) relapsed once. Of the four who relapsed twice, two showed an early relapse (symptoms reappearing five and fifteen days respectively after the end of chemotherapy), in addition to a "late" relapse eleven months and two and a half months respectively after the end of all treatment. In the late relapses (i.e., those in whom symptoms reappeared not earlier than approximately three weeks from the end of chemotherapy), the interval between the end of chemotherapy and the reappearance of the symptoms varied from twenty days to eleven months.
The interval between the original onset of symptoms and the first exhibition of M.&B. 693 had varied considerably: in four cases it had varied from 29 to 188 days, whilst in the remaining four, the original chemotherapy had been commenced somewhere between the third and the fourteenth day after the appearance of the symptoms. Three cases had had adjuvant treatment during chemotherapy, whilst a fourth had had urethral irrigations and vaccines for some considerable time before M.&B. 693 had been started. So that here again, neither "delayed therapy" nor adjuvant treatment appeared to play any vital part in the prevention of the relapse. This is rather at variance with the suggestion put forward by Cokkinis and McElligott (1939) that one cause for late relapses is the too early commencement of chemotherapy. These workers also consider that too short chemotherapy may likewise play a part in producing these relapses. In the series under discussion, relapses occurred in three of the early cases treated, when a more prolonged use of the drug as well as a larger dose were being employed than were used subsequently: whilst the maximum duration of the original chemotherapy in these cases was ten days, if too short chemotherapy were responsible for the reappearance of the symptoms, one would have expected a much higher percentage of late relapses in cases treated subsequently.
In three cases, relapses occurred after large amounts of alcohol, whilst in two cases, attendance during chemotherapy had been irregular. Whilst a vigorous denial of re-exposure was almost invariably given, one was suspicious that the reappearance of symptoms in one or two cases at least was the result of a fresh infection.
In these late relapses, the symptoms were often not typical of an acute infection: usually the patient complained of being damp, and on examination, urethral moisture rather than discharge was seen; this was often gonococcal negative. The urine became slightly hazy again and showed a reappearance of threads and pus cells. Where a copious urethral discharge was seen and where other symptoms typical of an acute attack were present, one was suspicious that the "relapse" was in reality a fresh infection. The symptoms and signs of the early relapse were essentially similar to those of the original attack.
Most of these cases responded satisfactorily to a second course of M.&B. 693, though one case required a much heavier dosage and more prolonged treatment than usual before his symptoms cleared up. Three cases defaulted either in the middle of treatment or before adequate follow-up after chemotherapy: it was interesting to note that these three patients had been irregular attenders during previous chemotherapy.
A point of importance, and one that has been stressed by Cokkinis and McElligott (1939) , is the fact that many of the patients in whom symptoms of late relapse occur had passed tests of cure successfully following their first course of treatment. From the facts recorded, it is suggestive that the most rigorous tests of cure in gonorrheea are indulgence in alcohol by the patient, and a prolonged follow-up after the end of chemotherapy. A prolonged follow-up has been the aim in this investigation, but unfortunately, in many cases, the patients failed to reappear a short time after the end of chemotherapy.
Even allowing for the fact that many patients defaulted before adequate followup, it seems evident that the relapse-rate with sulphonamide therapy is very much lower than following routine methods of treatment. An analysis of fifty cases of patients treated by routine methods will be referred to later; suffice it to say here that a relapse-rate of twenty-six per cent. was observed in the controls. That a high percentage of defaulters will report when symptoms reappear is evident from the fact that, of the eight relapsed cases discussed here, no fewer than three had defaulted before adequate follow-up after their first course of treatment. The views of a number of workers, therefore, as to the increased dangers of "gonococcal carriers" being at large as a result of these late sulphonamide relapses, hardly seems to be justified. Rather would it appear evident that the number of relapses is enormously reduced, and the possibilities of gonococcal carriers very much less, than in pre-sulphonamide days. It was a significant feature that out of the seventeen patients in Group A, no less than fourteen had had previous treatment by routine methods, whilst in the case of the remaining three patients, previous routine therapy may also have been employed, as the complication was present when these patients first reported at the cliniic. In eight of these seventeen cases, chemotherapy was commenced three weeks after the onset of symptoms of the acute attack of gonorrhcea, whilst in the remainder, the interval between the onset of symptoms and the beginning of chemotherapy varied from two to sixteen (lays. Iwo cases of arthritis occurred xvithin a few days from the beginning of the acute attack of gonorrhcea, whilst in the remaining twvo, the symptoms of arthritis had been present for two to three years. It has been mentioned that various workers have recommended a waiting period of from eight to twenty-one days from the onset of the symptoms of gonorrhcea until the beginning of chemotherapy, treatment in this period being confined to urethral irrigations and vaccines. That complications occurred in eight out of the seventeen patients in Group A dluring this interval, when urethral irrigations and in some cases vaccines were being employed, is a significant reply to those who advocate such a waiting period with adjuvant treatment before chemotherapy.
In discussing delayed therapy in connection with Uleron treatment of gonorrhcea, Marinkovitch (1939) states that some twenty per cent. of his cases developed complications mostly towards the end of the second week of treatment and before chemotherapy was commenced. GONOCOCCAL COMPLICATIONs-EPIDIDYMITIS.
In every case, the symptoms of the complication showedl an almost dramatic improvement with chemotherapy : this was most marked in the epiclidymitis cases. Almost always, the pain in these cases had gone by the morning following the beginning of chemotherapy, whilst the tenderness was usually gone by the third morning. Several of these cases still showed some residual thickening of the epi(lidvmis at the end( ol chemotherapy, but this almost invariably disappeared 85 during the next few weeks, and the organ became perfectly normal. So dramatic was the improvement in one case that the patient actually defaulted in the middle of treatment: he re-attended subsequently whep sent for, and reported perfectly fit.
Whilst this gratifying result was observed with the complications, the urethral discharge recurred in a number of cases as the epididymitis subsided or within a short time afterwards: in two cases the task of curing the discharge proved difficult with subsequent treatment: one of the cases not only showed a recurrence of his urethral discharge, but also developed an epididymitis on the opposite side from his original attack, ten days after withdrawal of M.&B. 693. Tab. sulphonamide-P (one gramme four times daily) was administered, but the discharge not only persisted but became more copious, whilst the epididymis increased in size, though the pain and tenderness were considerably eased. This patient defaulted before further adequate treatment.
The second patient showed a continuation of the urethral discharge throughout chemotherapy with M.&B. 693. Response to subsequent treatment with Uleron was also unsatisfactory, but he responded rapidly to a short course of urethral irrigations with 1/10,000 potassium permanganate following chemotherapy. These two cases have been termed chemotherapeutic failures, though it must be remembered that the complication for which the chemotherapy was originally instituted in each case was very greatly improved. It is possible, however, that a focus of infection may still have been present at the site of the complication.
Two other cases showed a "late" relapse, two months and twenty-four days respectively from the end of chemotherapy. One of these patients was showing a satisfactory response to routine treatment when he defaulted, the other case showed a rapid response to a further course of M.&B. 693. The first of these two patients is considered a chemotherapeutic failure, as his response to M.&B. 693 (though the drug caused a rapid improvement in his epididymitis) was unsatisfactory: he continued to complain of morning discharge in the interval between the end of chemotherapy and his relapse. Another patient again showed the same rapid improvement of his epididymitis, but defaulted a few days after the end of chemotherapy and when the urine was still showing threads and some pus cells: he, too, is considered as an M.&B. 693 failure, although his condition probably cleared up satisfactorily.
GONOCOCCAL COMPLICATIONS-VARIOUS.
Of the various complications in Group A, the origin of the conjunctivitis was doubtful, and no gonococci were found in the conjunctival sac: the conjunctivitis and accompanying urethral discharge cleared up rapidly with M.&B. 693, but it is possible that the eye condition would have shown an equally ready response to the adjuvant treatment of argyrol and atropine per se. In the case of the periurethral abscess, incision and drainage were followed by a rapid amelioration in symptoms, whilst the urine became sterile a few days after the first exhibition of M.&B. 693. Twice-daily catheterisation was necessary to relieve the retention overflow during the first two days in the sixth case of this series: this treatment alone in another 86 hospital, however, had failed to relieve his symptoms: the combination of M.&B. 693, however, appeared to bring about a successful issue within a few days. GONOCOCCAL COMPLICATIONS-ARTHRITIS. As in the other complications, the amelioration of symptoms in both acute and chronic gonococcal arthritis was often quite dramatic, and all cases at least showed an improvement.
One case was particularly interesting: this man had had symptoms of arthritis, especially affecting his wrist and hand joints, off and on for two years. M.&B. 693 was started (three grammes daily) and continued for four days, after which time it was withdrawn on account of toxic symptoms. The pains had improved greatly, but recurred slightly following cessation of chemotherapy. A further three grammes per day were given for three more days. He reported at intervals for a further four months. By the end of three months he stated that in the interval he had been able to "go hard at it" from 9 a.m. until 6 p.m.: this was the first time he had been able to work like this since the onset of his complaint.
Dosage of the drug in all these complicated cases was largely experimental, but it was found, as before, that very often an equally good result was obtained by comparatively small doses as that obtained with larger ones, though in the case of arthritis, chemotherapy was usually carried on for a considerably longer period than in the other complications. It again became evident that where a satisfactory response to sulphonamide therapy was not obtained within the first day or two, a failure was almost certainly inevitable. Despite this, the continuation of chemotherapy in the case of complications would appear to be justified, at least for a number of days, as the response of the complication was almost always so gratifying. It again became evident, too, that failure with M.&B. 693 was frequently followed by failure with other sulphonamides.
Adjuvant treatment was employed occasionally. In addition, in almost every case of epididymitis, support for the affected organ was insisted upon.
That failure to respond to chemotherapy is due in part to poor absorption of the drug, became evident from the study of the absorption and excretion of M.&B. 693 in some of those cases where an unsatisfactory response was seen. Apart from the poor absorption of the drug, however, another obvious cause for chemotherapeutic failure and relapse in gonorrhoea becomes evident from the study of these complications. Four out of seventeen (23.5 per cent.) of these cases (excluding the patients suffering from arthritis) were ultimate failures with sulphonamide therapy, despite marked improvement in the complications complained of, whilst two cases (almost twelve per cent.) were "late" relapses. It is possible that some at least of the failures or late relapses recorded by other workers may be due to a slight complication which had been overlooked, and it would appear to be advisable that where a chemotherapeutic failure or relapse is recorded, a thorough examination be made for any possible complication, however slight.
Since failure and relapse are thus more common in complicated than uncomplicated cases, another point in favour of early chemotherapy becomes evident, since it has been shown that gonococcal complications do not usually occur where the 87 disease is confined to the anterior urethra, but become comparatively frequent when the posterior urethra becomes involved. II. TREATED WITH ULERON ONLY OR ULERON AND M.&B. 693.
Space does not permit any detailed description of the cases treated by Uleron nor were the results sufficiently encouraging to justify a long report. Several points of interest arose. In the first place, the average cure with Uleron was somewhere between fifty and sixty per cent., a figure very much below that obtained with M.&B. 693, whilst the average total duration of treatment was considerably longer than with that drug. It again became evident that where one drug failed, the results obtained with the other were often no more encouraging, though this was not invariable. "Delayed chemotherapy" and adjuvant treatment gave rather better results when used in conjunction with Uleron than when Uleron was used alone. III. CONTROLS-50 PATIENTS.
The fifty control patients were chosen at random from those cases who had been treated by routine methods of daily urethral irrigations and weekly injections of gonococcal vaccine. In order to obtain a better general perspective of the results of routine treatment, these cases were chosen from a series who had been treated before the introduction of sulphonamide therapy for gonorrheea.
The only criteria which were looked for in the cases chosen as controls were that the patients had attended reasonably well during treatment, and that they had been subsequently discharged as cured.
They were analysed, in the main, from three aspects Not only is gonorrhoea in the female patient difficult to treat, but the organism, especially in old standing cases, is difficult to isolate and culture. An attempt was made to isolate and culture the organism in most of the cases treated, but this was often unsuccessful, and the condition was treated as the result of the clinical diagnosis of acute or chronic gonorrhoea. Unfortunately, the female is much less tolerant than the male to the sulphonamides, and nausea and vomiting are comparatively frequent, so that co-operation in chemotherapy is often more difficult to obtain than in men. Moreover, the series here considered is rather small for any definite conclusions to be reached as to the appropriate dosage of the drug required, the necessity or otherwise of adjuvant treatment, and the ultimate result following chemotherapy in the female. The results obtained even from this small series leave little doubt that the response of gonococcal conditions to chemotherapy 88 in the female is as encouraging (given favourable conditions) as in the male. Whilst most of the cases treated at least showed considerable improvement in their condition (only one failing to do so), several are of special interest.
One was a woman of 33 years of age, who had had a heavy vaginal discharge following a confinement seven years previously: the discharge had become worse during the last three years, during which time she had had conservative treatment off and on. She was started on M.&B. 693 (0.5 grammes four times daily) and chemotherapy was continued for fourteen days. At the beginning of chemotherapy there was pus in the urethra, a heavy vaginal discharge, and the cervix was eroded: when M.&B. 693 was withdrawn, the discharge had ceased and the cervical erosion was greatly improved. The improvement was not only maintained, but became more pronounced, and two months later the patient stated that for the first time for three years she had been able to do without a vulval pad: on examination the only pathology seen was a slight cervical erosion. She subsequently became pregnant after an interval of seven years, during which time she stated that no contraceptive methods had been employed. Unfortunately, she developed a high blood pressure and albuminuria, and the pregnancy had to be terminated at the seventh month: the infant did not live.
Two other cases failed to respond to the oral administration of M.&B. 693, but shoowed satisfactory progress when intramuscular preparations of the drug were used in conjunction with the tablets. It is probable that oral administration alone was insufficient to give a sufficiently high concentration of the drug in the blood to be really effective in these two cases, and that this was overcome only when the more readily absorbed preparations were used. The second patient was an irregular attender, and that this was also partly responsible for the failure to respond to oral therapy alone is not unlikely, and experience would tend to show that continuous treatment is highly important when chemotherapy is being employed.
Two cases were victims of gonococcal arthritis before chemotherapy. Both responded well to M.&B. 693, though one showed a subsequent relapse; the relapse was accompanied by less severe pain than was experienced at the earlier attack.
ADMINISTRATION OF THE DRUGS AND ADJUVANT TREATMENT. M.&B. 693.
Various schemes of dosage of M.&B. 693 were tried in the early part of this work, and had to be abandoned or modified for one reason or another. A considerably larger dose was used at the beginning than is now employed, but it was found that minor toxic reactions with these larger doses were comparatively frequent and patients complained of headache, nausea, flatulence, and many other unpleasant minor reactions. A number of patients then defaulted in the middle of chemotherapy, after having had a much smaller quantity of M.&B. 693 than the majority of cases: some of these defaulters reported subsequently and were found to have been perfectly well in the interval. In addition, from the study of the toxicity of the drug (a summary of which is described elsewhere in this Journal), it soon became evident that M.&B. 693 was much more toxic than early experimental evidence had promised. A consideration of these facts suggested that not only was a modified dosage of the drug likely to be as successful as the larger doses being employed, but that such a modification was highly desirable if the possibility of serious toxic reactions was to be reduced to a minimum. Dosage was subsequently reduced, and it was gratifying to find that not only was the frequency of minor toxic reactions much less, but the clinical response was equally good.
The dosage finally decided upon in the treatment of acute and chronic uncomplicated gonorrhoea in the male was 3 gm. of the drug on the first.day, the drug being taken in divided doses at intervals which were considered to be sufficient to give a reasonably steady blood concentration, i.e., 1 gm. immediately after examination (about 10 a.m.), 0.5 gm. at 2 p.m., 0.5 gm. at 6 p.m., and 1 gm. at bedtime. The following six days, 0.5 gm. four times daily, was taken at approximately the same time as on the first day. After seven days' treatment the drug was withheld. It was occasionally found that a few small specks were still present in the urine, but these usually cleared up within a few days' time without further treatment. When the specks persisted or when symptoms reappeared (which was seldom), a further seven-day course similar to the first was started.
Where disappearance of the discharge was not seen by the second or third day, the dose was increased (provided no toxic symptoms were seen), as it was considered that the failure to respond to routine dosage was possibly due to poor absorption of the drug. If this procedure was still rewarded by failure (which again was seldom), or where signs of toxicity followed the use of the larger doses, the drug was withheld and other sulphonamides were administered or routine treatment was instituted.
In complicated cases a similar dosage was often found to be equally effective, though treatment was sometimes more prolonged (especially in arthritis cases) than in uncomplicated cases.
Thus dosage and the duration of chemotherapy are considerably less than those recommended by the majority of workers, but the results obtained and the other factors considered would appear to more than justify their continuance.
That the treatment of the female was made more difficult on account of the greater susceptibility to the toxic effects of the drug in this sex than in the male has been mentioned. Unfortunately, decreasing the dosage of the drug in the female was not followed by the same encouraging decreasAe in "minor" toxic symptoms as was observed in the case of men, and other methods for overcoming these unpleasant effects were adopted. These included giving the tablets suspended in, or in combination with, glucose or alkalis or in giving a smaller dose at more frequent intervals (i.e., half a tablet every two hours rather than a whole tablet every four hours). These methods were followed by success of varying degree in different patients, but no hard and fast rule could be laid down to avoid toxicity in all cases, and in some patients, all efforts resulted in failure to avoid nausea or vomiting or both. In these cases, as in the males, the drug was stopped and another sulphonamide was given or routine measures of treatment adopted. It was found, on the whole, that more prolonged dosage was necessary in the treatment of gonorrhoea in the female than in the male, and that less toxicity was observed 90 when small doses were given at frequent intervals. The majority of female cases treated were given 0.5 gm. of M.&B. 693 four times daily (or 0.25 gm. two-hourly) for fourteen days where possible. ULERON. Uleron was administered in doses of 3 gm. per day for four days, followed by a perio(d of seven to eight days' rest, when a second "stoss" similar to the first was given, and after a further interval of rest as before, a third similar "stoss" was administered. The minor toxic reactions due to this drug were found to be much less common than with M.&B. 693, but the major toxic possibilities were found to be just as serious. In addition, adequate treatment with the drug was found to be much more prolonged and tedious than with M.&B. 693, and the clinical results less convincing. As a result, Uleron has only been used in the treatment of a comparatively few cases.
The broad outline upon which treatment and follow-up were based was as follows:-With a male patient, on his first appearance at the clinic, the history was taken and a careful note of the clinical condition was made. A smear was taken from the urethral discharge and in a number of cases the discharge was cultured: the smear was stained by the Gram method and examined for the gonococcus. Where a syphilitic infection was suspected as well, a drop of serum from the suspected chancre was examined by darkground illumination: if this was positive, arsenical treatment was at once instituted, and the gonococcal infection was treated by routine methods, as it was considered unwise to employ two drugs together, either of which was capable of causing agranulocytosis per se. In one case only were M.&B. 693 and neoarsphenamine employed together, and no ill-effects resulted. Actually, a rapid response to treatment was observed in both diseases in this patient, though the gonorrhoea was longer in clearing up with M.&B. 693 than usual.
Where chemotherapy was decided upon, the patient was told to avoid all sulphurcontaining foods and to use only mild laxatives, when any laxative was necessary, and he was warned to abstain from alcohol and sexual excitement until such times as his condition was cured. The-following day chemotherapy was commenced with the chosen drug, and the patient was seen daily during the time the drug was being taken, only one day's supply of tablets being given at each visit. On each visit a smear and, in a number of cases, a culture also were made where possible from the urethral discharge, until such times as the discharge became gonococcal negative: in many cases, however, the discharge had cleared up by the following morning, whilst in others it was very much reduced, and almost always no gonococci were found. Where there was no discharge present, a sample of urine was centrifuged and the centrifuged deposit examined for the organism. At the end of chemotherapy, a further sample of urine was similarly examined, and the patient told to report in three to four days' time, and if everything was satisfactory, to report at weekly intervals for a further period. This follow-up period varied, the aim being to see the patient at intervals for as long a time as possible, and at least for a further 91 three months from the end of chemotherapy. With Uleron, the main line of treatment was similar to that for M.&B. 693 except that smears from the urethral discharge or a centrifuged deposit of urine were examined before and after and on the second day of each "stoss," or, where the discharge persisted, a daily smear was examined for the gonococci until the discharge became gonococcal negative.
In the case of females, a careful vaginal and bi-manual examination were performed and smears and culture from the urethra, Bartholin's glands, or the cervix were made. It has been mentioned, however, that these were often negative, and the condition was treated as a result of the clinical diagnosis of acute or chronic gonorrhoea. Follow-up and adequate tests of cure were very much more unsatisfactory than in the male.
The procedures described above are, in the main, those now adopted in the treatment of gonorrhoea at the Venereal Diseases Clinic of the Royal Victoria Hospital, Belfast. Three other things remain to be said.
It has been shown that adjuvant treatment makes little difference to the ultimate outcome of acute cases of gonorrhoea treated by M.&B. 693. Whilst this is true in the majority of cases, one or two patients did show a more rapid response to treatment when urethral irrigations were employed after the first day or two of chemotherapy alone. In addition, it was felt that possibly the use of urethral irrigations might help to prevent the high default-rate which was evident when chemotherapy only was used. As a result, on his first appearance at the clinic and during chemotherapy, the patient is now given urethral irrigations of 1 in 10,000 permanganate potassium in addition to M.&B. 693. A further point of importance is, that during the follow-up period the patient's blood is examined to exclude the possibility of syphilis. The tests performed are the Wassermann reaction (using the Harrison and Fleming techniques), and, where a doubtful positive result is obtained, a Dreyer flocculation test is also carried out.
Finally, one method suggested by Wilkie (1939) to combat defaulters is that patients should be requested by letter to reattend hospital when they fail to reappear after an interval. The majority of defaulters in the present investigation were requested to reattend for re-examination once, twice, or even three times, but only a very small percentage turned up and frequently they again defaulted. In many cases the communications sent were returned as "not known" or "wrong address" ' 92 
